Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain. 1990;41(3):273-281. doi:10.1016/0304-3959(90)90004-W

Snijders RAH, et al. Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis. Cancers (Basel). 2023;15(3):591. doi:10.3390/cancers15030591

Deandrea S, et al. Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manage. 2014;47(1):57-76. doi:10.1016/j.jpainsymman.2013.05.016

Margari F, et al. Quality of Life in Patients with Breakthrough Cancer Pain: A Systematic Review. Future Oncol. 2020;16(36):943-954. doi:10.2217/fon-2020-1063

Oldenmenger WH, et al. A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal. Eur J Cancer. 2009;45(8):1370-1380. doi:10.1016/j.ejca.2009.01.007

Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era. CA Cancer J Clin. 2018;68(3):182-196. doi:10.3322/caac.21453

Mercadante S, et al. A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study. J Clin Med. 2021;10(11):2273. doi:10.3390/jcm10112273

Lu Y, et al. Barriers to cancer pain management in nurses in China: A systematic review. J Nurs Scholarsh. 2021;53(6):708-717. doi:10.1111/jnu.12644

Zeppetella G. Breakthrough pain in cancer patients. Clin Oncol. 2011;23(6):393-398. doi:10.1016/j.clon.2011.03.001

Cascella M, et al. Identification of Distinct Phenotypes of Breakthrough Cancer Pain: A Cluster Analysis from the IOPS-MS Study. Pain Ther. 2021;10(2):1233-1244.

Pantano F, et al. Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study. JCO Precis Oncol. 2020;4:PO.20.00158.

Mercadante S, et al. A longitudinal study of breakthrough cancer pain: An extension of IOPS-MS study. J Clin Med. 2021;10(11):2273.

Vellucci R, et al. Heterogeneity of breakthrough cancer pain: findings from a multicenter observational study. Pain Med. 2020;21(4):722-728. doi:10.1093/pm/pnz279

Wang Y, et al. Patterns of analgesic use in cancer patients in China: a population-based study. Ther Clin Risk Manag. 2018;14:2331-2339. doi:10.2147/TCRM.S175321

Hagen NA, et al. Assessment and management of breakthrough pain in cancer patients. Curr Opin Support Palliat Care. 2018;4(2):101-106. doi:10.1097/SPC.0000000000000334

Mercadante S, et al. Factors influencing the use of opioids for breakthrough cancer pain. Pain. 2018;159(1):164-167.

Lee J, et al. Prediction of the breakthrough cancer pain using deep learning model. J Clin Oncol. 2021;39(15_suppl):e24085.

Salama M, et al. Artificial intelligence in cancer care: a systematic review. J Cancer. 2022;13(15):3684.

Ko RE, et al. Machine learning-based mortality prediction model for critically ill cancer patients admitted to the intensive care unit (CanICU). Cancers. 2023;15(3):569.

Johnson AEW, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10(1):1.

Zhao Y, et al. Machine learning for predicting survival of cancer patients in the ICU. Front Oncol. 2021;11:665228.

Zhang Z, et al. Predictive analytics with gradient boosting machines. Ann Transl Med. 2019;7(7):152.

Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44-56.

Rajkomar A, et al. Scalable and accurate deep learning with electronic health records. NPJ Digit Med. 2018;1:18.

Swarm RA, et al. Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(8):977-1007.

Fallon M, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv166-iv191.

Greco MT, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014;32(36):4149-4154.

Yang Y, et al. A systematic review and meta-analysis of randomized controlled trials of palliative care for pain among Chinese adults with cancer. BMC Palliat Care. 2019;18(1):68.

Lu Y, et al. Barriers to cancer pain management in nurses in China: A systematic review. J Nurs Scholarsh. 2021;53(6):708-717.

Chen Y, et al. Opioid prescribing for cancer pain in China: a population-based study. BMC Health Serv Res. 2021;21:1152.

Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting System. KDD '16. 2016:785-794.

Lundberg SM, Lee SI. A Unified Approach to Interpreting Model Predictions. NeurIPS. 2017:4765-4774.

Pollard TJ, et al. The eICU Collaborative Research Database. Sci Data. 2018;5:180178.

Van Calster B, et al. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17(1):230.

Steyerberg EW, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128-138.

Dowell D, et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recomm Rep. 2022;71(3):1-95.

Azizoddin DR, et al. Psychological evaluation of patients with cancer presenting to the emergency department with pain. JCO Oncol Pract. 2022;18(10):e1648-e1660.

Sostres C, et al. Pharmacological treatment of breakthrough cancer pain: a review. Expert Opin Pharmacother. 2020;21(11):1367-1376.

Pigni A, et al. Breakthrough pain validation of a questionnaire. J Pain Symptom Manage. 2021;61(5):980-988.

Farrar JT, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149-158.

Breivik H, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287-333.

Cleeland CS, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592-596.

Bhatia A, et al. Artificial intelligence in cancer pain management: a systematic review. Pain Med. 2023;24(8):931-942.

Bennett MI, et al. Classifying the mechanism of cancer pain: a systematic review. Pain. 2019;160(1):21-27.

World Health Organization. WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain. 2018.

Caraceni A, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):e58-e68.

Løhre ET, et al. Clinical characteristics of breakthrough cancer pain: a systematic review. J Pain Symptom Manage. 2016;51(6):1013-1023.

Tagami K, et al. Breakthrough cancer pain in outpatient palliative care: a multicenter observational study. J Palliat Med. 2018;21(8):1106-1111.

Schmidt BL. The neurobiology of cancer pain. Neuroscientist. 2014;20(5):546-562. doi:10.1177/1073858413511538
